Realtime | Geld | Brief | Zeit |
---|---|---|---|
0,074 | 0,094 | 18:38 |
Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
23.09. | HVIVO Slides To Loss In H1 | - | RTTNews | ||
23.09. | hVIVO PLC - Interim results | - | RNS | ||
04.09. | hVIVO PLC - Notice of Results | 4 | RNS | ||
HVIVO Aktie jetzt für 0€ handeln | |||||
01.09. | hVIVO appoints Avacta Chair Shaun Chilton to lead board | 1 | Alliance News | ||
01.09. | hVIVO PLC - Appointment of Non-Executive Chair | - | RNS | ||
29.07. | hVIVO PLC - Proposed appointment of Chair | - | RNS | ||
22.07. | TRADING UPDATES & EARNINGS: hVIVO expects interim revenue decline | 2 | Alliance News | ||
22.07. | hVIVO PLC - H1 Trading update | 1 | RNS | ||
18.07. | hVIVO PLC - Directorate Change | - | RNS | ||
09.07. | hVIVO PLC - Notice of Trading Update | - | RNS | ||
30.06. | hVivo reports positive results from its largest lab contract to date | 1 | Sharecast | ||
30.06. | hVIVO reports positive results from Cidara's Phase 2b influenza study | 3 | Investing.com | ||
30.06. | hVIVO PLC - Positive results from client Phase 2b field study | - | RNS | ||
05.06. | hVIVO PLC - Result of AGM | - | RNS | ||
02.06. | DIRECTOR DEALINGS: hVIVO CEO buys shares; Investec execs sell stock | 2 | Alliance News | ||
02.06. | hVIVO PLC - Director/PDMR Shareholding | - | RNS | ||
30.05. | hVIVO stock plunges after contract cancellations in 'depressed' market | 1 | Alliance News | ||
30.05. | Hvivo shares tank after contract cancellations | 4 | Shares | ||
30.05. | AIM WINNERS & LOSERS: hVIVO shares dive on contract cancellations | 1 | Alliance News | ||
30.05. | Hvivo client cancels 'significant' HCT trial contract | 1 | Sharecast |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
PLUS THERAPEUTICS | 0,730 | +7,76 % | Plus Therapeutics Inc.: Plus Therapeutics Announces National Coverage Agreement with UnitedHealthcare Insurance Company for CNSide Cerebrospinal Fluid Assay for Metastatic CNS Cancer | HOUSTON, Sept. 25, 2025 (GLOBE NEWSWIRE) -- CNSide Diagnostics, LLC, a wholly-owned subsidiary of Plus Therapeutics, Inc. (Nasdaq: PSTV) ("Plus" or the "Company"), announced today that it has signed... ► Artikel lesen | |
JD HEALTH INTERNATIONAL | 7,250 | -1,36 % | Aktie von JD Health büßt 2,73 Prozent ein (7,125 €) | An der Börse notiert die JD Health-Aktie zur Stunde ein wenig leichter. Zuletzt zahlten Investoren für die Aktie 7,13 Euro. Die Aktie von JD Health verzeichnet gegenwärtig einen Kursrückgang von 2,73... ► Artikel lesen | |
LIFEWARD | 0,750 | -2,55 % | Lifeward Ltd.: Lifeward Achieves CE Mark Approval for the ReWalk 7 Personal Exoskeleton | MARLBOROUGH, Mass. and YOKNEAM ILLIT, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd., (Nasdaq: LFWD) ("Lifeward" or the "Company"), a global leader in innovative medical technology to transform... ► Artikel lesen | |
EKSO BIONICS | 5,680 | +7,58 % | Ekso Bionics Holdings, Inc.: Ekso Bionics Reports Second Quarter 2025 Financial Results | SAN RAFAEL, Calif., July 28, 2025 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) ("Ekso Bionics" or the "Company"), an industry leader in exoskeleton technology for medical and industrial... ► Artikel lesen | |
IMUNON | 4,440 | -3,90 % | Imunon, Inc.: IMUNON Successfully Regains Compliance with Nasdaq Minimum Bid Price Listing Requirement | LAWRENCEVILLE, N.J., Aug. 28, 2025 (GLOBE NEWSWIRE) -- IMUNON, Inc. (Nasdaq: IMNN), a clinical-stage company in Phase 3 development of its DNA-mediated immunotherapy, today announced that the Company... ► Artikel lesen | |
BIOCEPT | 7,200 | 0,00 % | GlaxoSmithKline Bioc: Gewinn im zweiten Quartal bei 5,9 Mio. EGP | ||
ROCKWELL MEDICAL | 1,032 | +0,39 % | Rockwell Medical promotes Heather Hunter to COO | ||
AVINGER | 0,465 | -22,17 % | NSE - Avinger Inc - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities | ||
VIRIDIAN THERAPEUTICS | 18,405 | +1,60 % | Viridian Therapeutics announces inducement grants under Nasdaq listing rule 5635(c)(4) | ||
SINTX TECHNOLOGIES | 3,930 | -4,15 % | Sintx Technologies files to sell 541,450 shares of common stock for holders | ||
AETHLON MEDICAL | 1,430 | -100,00 % | Stocks Moving Premarket: Aethlon Medical, Tharimmune, Brazil Potash And Other Gainers & Losers | OTTAWA (dpa-AFX) - At 7:32 a.m. ET on Thursday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
STAGEZERO LIFE SCIENCES | 0,028 | -100,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 28.08.2025 | The following instruments on Boerse Frankfurt do have their last trading day on 28.08.2025.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 28.08.2025.ISIN NameAU000000DHG9 DOMAIN... ► Artikel lesen | |
SAVARIA | 12,400 | -1,59 % | Dividendenbekanntmachungen (29.09.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ACADIAN TIMBER CORP CA0042721005 0,29 CAD 0,1777 EUR ACOM CO LTD JP3108600002 10 JPY 0,0572 EUR ADVANTEST CORPORATION JP3122400009 19... ► Artikel lesen | |
NEURONETICS | 2,360 | +3,74 % | Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | MALVERN, Pa., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve... ► Artikel lesen | |
ARCH THERAPEUTICS | - | - | Arch Therapeutics, Inc. - 8-K, Current Report |